Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy

Stephen Massia (Inventor)

Research output: Patent

Fingerprint Dive into the research topics of 'Bioselective Targeting Dextran Bioconjugate Anti-Inflammatory/Immunosuppressant Therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences